Ex Parte Rioux et al - Page 6

                 Appeal 2007-2813                                                                                      
                 Application 10/685,744                                                                                

                 of different ‘open cell’ porous materials,” for example, porous sintered                              
                 metal, such as from stainless steel (id. at col. 5, ll. 41-46).  Alternatively,                       
                 VanTassel describes creating a porous distal portion “from a non-porous                               
                 material (e.g., metal) using a cutting laser and techniques known in the art to                       
                 punch pores into the needle segment” (id. at col. 6, ll. 12-15).                                      
                        We agree with the Examiner’s reasoning that it would have been                                 
                 prima facie obvious to form Edwards’ fluid distribution ports by either of the                        
                 techniques described in VanTassel.  Specifically, we agree that it would                              
                 have been prima facie obvious to incorporate the fluid distribution ports by                          
                 utilizing a porous material, such as sintered stainless steel.                                        
                        Appellants argue that VanTassel is not analogous prior art because                             
                 “VanTassel is neither in the field of the inventors’ endeavor nor is it                               
                 reasonably pertinent to the particular problem with which the inventors were                          
                 concerned” (Br. 5).1  Specifically, Appellants argue that                                             
                        the field of the inventors’ endeavor is the ablative treatment of                              
                        tumors . . . , whereas the field that VanTassel is concerned with                              
                        is the injection of medicaments into tissue. . . .  Furthermore,                               
                        the particular problem with which the inventors were concerned                                 
                        with was making therapeutic ablations more efficient . . . ,                                   
                        whereas the particular problem solved by VanTassel was                                         
                        providing a means for microinjecting controlled amounts of                                     
                        injectate to minimize leakage otherwise due to the rapid transfer                              
                        of fluid.                                                                                      
                 (Id. at 5.)                                                                                           
                        We are not persuaded by this argument.  “In order to rely on a                                 
                 reference as a basis for rejection of the applicant’s invention, the reference                        
                                                                                                                      
                 1 Our citations are to the “Supplemental Appeal Brief” filed September 5,                             
                 2006.                                                                                                 
                                                          6                                                            

Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next

Last modified: September 9, 2013